STAT3 and cancer: This directed delivery of siRNA targeting the STAT3 gene (ESTA-MSV/STAT3 siRNA) knocked down STAT3 protein production in nearly 50% of cancer cells in the bone and led to enhanced survival (25% extension of life) in mice bearing MDA-MB-231 bone metastasis.